StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
35
This month
2
This year
6
Publishing Date
2024 - 04 - 09
1
2024 - 04 - 01
1
2024 - 02 - 06
1
2024 - 01 - 30
1
2024 - 01 - 23
1
2024 - 01 - 08
1
2023 - 11 - 15
1
2023 - 11 - 14
1
2023 - 11 - 06
1
2023 - 10 - 10
1
2023 - 09 - 20
4
2023 - 09 - 19
1
2023 - 05 - 22
1
2023 - 05 - 15
1
2023 - 05 - 01
1
2023 - 04 - 25
1
2023 - 03 - 28
2
2023 - 03 - 24
1
2023 - 01 - 24
1
2023 - 01 - 04
1
2022 - 12 - 19
1
2022 - 12 - 01
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 08
1
2022 - 10 - 12
1
2022 - 09 - 28
1
2022 - 09 - 14
1
2022 - 09 - 06
1
2022 - 09 - 01
2
Sector
N/a
1
Professional, scientific, and technical services
2
Tags
Acquisition
1
Award
2
Biotech-bay
1
Biotech-beach
4
Biotechnology
3
Business
1
Cancer
7
Conference
2
Cypath
1
Earnings
1
Events
3
Financial
7
Flow
2
For
1
Growth
1
Health
1
Initiative
1
Lone-star-bio
4
Lung
7
Management
1
Medical
1
Meeting
1
Mergers-and-acquisitions
1
Money
1
N/a
10
Network
2
Offering
2
One
1
Patent
2
People
3
Prime
1
Publication
2
Report
4
Research
8
Respiratory
1
Results
8
Sales
1
Services
1
Symposium
1
Technology
1
Treatment
1
Trial
1
Update
2
Year
1
Entities
Bgc group, inc.
1
Bioaffinity technologies, inc.
35
Icoreconnect inc.
2
Symbols
AAPL
1194
ABB
1423
ABBV
1023
ABLZF
1162
ABT
1784
ACN
600
AMGN
742
ARVL
4286
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
896
DHR
785
ERIC
1608
F
641
FNCTF
7171
FRBA
595
GE
915
GLAXF
657
GOOG
1274
GOOGL
1273
GSK
883
HON
1779
HUBS
1400
IBM
654
INTC
954
IT
590
JNJ
4571
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4281
MSFT
1199
MT
588
NOC
589
NOK
899
NOKBF
973
NVO
631
NVS
1241
NVSEF
1031
ORCL
1157
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1126
PPRUY
1127
SAP
1474
SAPGF
1228
SNOW
794
SNY
4532
SNYNF
3590
TEVJF
630
TMO
1621
VZ
1211
XYF
674
Exchanges
Nasdaq
35
Crawled Date
2024 - 04 - 09
1
2024 - 04 - 01
1
2024 - 02 - 06
1
2024 - 01 - 30
1
2024 - 01 - 23
1
2024 - 01 - 08
1
2023 - 11 - 15
2
2023 - 11 - 06
1
2023 - 10 - 10
1
2023 - 09 - 20
4
2023 - 09 - 19
1
2023 - 05 - 22
1
2023 - 05 - 15
1
2023 - 05 - 01
1
2023 - 04 - 25
1
2023 - 03 - 28
2
2023 - 03 - 24
1
2023 - 01 - 24
1
2023 - 01 - 04
1
2022 - 12 - 19
1
2022 - 12 - 01
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 08
1
2022 - 10 - 12
1
2022 - 09 - 28
1
2022 - 09 - 14
1
2022 - 09 - 06
1
2022 - 09 - 01
2
Crawled Time
00:00
1
12:00
1
12:20
2
13:00
8
13:20
1
13:30
3
14:00
5
14:30
3
15:00
3
16:00
1
17:00
3
22:00
2
23:00
2
Source
feed.businesswire.com
3
spacfeed.com
4
www.biospace.com
25
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
BIAF
save search
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
Published:
2023-01-24
(Crawled : 15:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
77.99%
|
O:
20.13%
H:
108.9%
C:
46.07%
research
respiratory
trial
results
publication
PRIME AE Enhances Midwest Presence with Jacobi, Toombs … – PR Newswire
Published:
2023-09-20
(Crawled : 22:00)
- spacfeed.com
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
83.77%
|
O:
-9.09%
H:
2.14%
C:
-24.29%
ICCT
|
$1.18
-6.35%
-6.78%
34K
|
Professional, Scientific, and T...
|
-69.47%
|
O:
-6.11%
H:
21.95%
C:
10.03%
prime
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF … – PR Newswire
Published:
2023-09-20
(Crawled : 22:00)
- spacfeed.com
BGC
|
$7.515
-0.73%
-0.73%
2.7M
|
n/a
|
42.56%
|
O:
-2.07%
H:
3.37%
C:
1.73%
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
83.77%
|
O:
-9.09%
H:
2.14%
C:
-24.29%
ICCT
|
$1.18
-6.35%
-6.78%
34K
|
Professional, Scientific, and T...
|
-69.47%
|
O:
-6.11%
H:
21.95%
C:
10.03%
network
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
Published:
2022-11-10
(Crawled : 15:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
18.66%
|
O:
1.05%
H:
14.52%
C:
6.22%
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
Published:
2023-05-01
(Crawled : 13:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
45.13%
|
O:
-0.51%
H:
7.22%
C:
5.67%
financial
bioAffinity Technologies Reports First Quarter 2023 Financial Results
Published:
2023-05-15
(Crawled : 14:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
52.97%
|
O:
-5.37%
H:
5.67%
C:
3.96%
financial
results
bioAffinity Technologies Presents Research Findings at CYTO 2023
Published:
2023-05-22
(Crawled : 14:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
54.64%
|
O:
0.0%
H:
3.83%
C:
3.83%
research
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published:
2023-11-14
(Crawled : 00:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
97.43%
|
O:
-2.33%
H:
7.14%
C:
2.93%
business
update
financial
results
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published:
2022-12-01
(Crawled : 14:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
4.81%
|
O:
1.26%
H:
2.05%
C:
1.32%
research
meeting
cancer
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-04-01
(Crawled : 17:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
40.1%
|
O:
2.97%
H:
1.92%
C:
0.48%
year
financial
results
WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
Published:
2022-09-01
(Crawled : 17:00)
- prnewswire.com
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
Email alert
Add to watchlist
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
Published:
2022-11-14
(Crawled : 13:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
0.0%
|
O:
-2.83%
H:
1.82%
C:
0.0%
financial
update
results
bioAffinity Technologies Announces Pricing of IPO
Published:
2022-09-01
(Crawled : 12:20)
- feed.businesswire.com
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
Email alert
Add to watchlist
technology
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Published:
2022-10-12
(Crawled : 13:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
1.07%
|
O:
0.0%
H:
2.68%
C:
-0.36%
lung
conference
flow
results
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board
Published:
2024-02-06
(Crawled : 13:30)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
79.57%
|
O:
-0.38%
H:
0.64%
C:
-0.64%
lung
network
medical
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
Published:
2022-11-08
(Crawled : 13:20)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
6.79%
|
O:
-0.18%
H:
5.22%
C:
-0.96%
report
financial
results
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published:
2023-04-25
(Crawled : 13:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
38.05%
|
O:
2.44%
H:
0.0%
C:
-2.38%
lung
symposium
cancer
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published:
2023-11-15
(Crawled : 14:00)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
96.39%
|
O:
0.6%
H:
0.0%
C:
-2.39%
lung
cancer
bioAffinity Technologies In The News - January 30, 2024
Published:
2024-01-30
(Crawled : 13:30)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
76.88%
|
O:
2.5%
H:
0.51%
C:
-2.44%
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published:
2024-01-23
(Crawled : 14:30)
- biospace.com/
BIAF
|
$2.9
2.47%
2.41%
210K
|
|
87.42%
|
O:
5.3%
H:
0.0%
C:
-2.52%
award
patent
cancer
treatment
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.